AN African Union Commission assessment mission is in Zimbabwe to assess and evaluate the country’s bid to host the African medicines agency (AMA) headquarters.
Zimbabwe and 14 other African Union Commission members are bidding to host the African Medicines Agency headquarters and this morning, the nine-member African Union delegation met officials from the Ministry of Foreign Affairs and International Trade as well as those from the Ministry of Health and Child Care.
“As Zimbabwe, we are excited that finally the African Union Commission (AUC) initiative to establish AMA, in line with Africa’s Agenda 2063 vision for socio-economic and structural transformation that defines the health and well-being of African as both foundational and fundamental is now materialising. For us participating in this endeavour is a dream come true. Ladies and Gentlemen. It is our hope that the agency will promote the use of quality assured, safe and efficacious medicines, medical products and medical technologies in Africa. I would like to note the significance of AMA in the wake of the COVID-19 pandemic,” said Ambassador Frederick Shava, Minister of foreign affairs and international trade.
The nine-member African Union Commission delegation led by Professor Aggrey John is on a three-day working visit to assess and evaluate Zimbabwe’s suitability to host the African Medicines Agency – AMA headquarters.
“We want to thank the government of Zimbabwe for the major investments that have been made in the AMA process. The intellectual capital that Zimbabwe has invested in this process is quiet enormous. I must also congratulate Zimbabwe for being part of this process in the bid to host the AMA headquarters in accordance of the provisions of the AMA treaty where the opportunity to host the AMA headquarters is open to all 55-member states of the AU. This morning we are assessing the 8th country,” said Professor John.
The delegation is expected to visit the Medicines Control Authority of Zimbabwe (MCAZ), which boasts of World health Organisation pre-qualification, ISO certified and internationally accredited laboratories, making it a regional centre for regulatory excellence in quality control and quality assurance of medicines.
The assessment process started in East Africa on the 6th of March before moving to North Africa and the SADC region.